Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 8914

1.

Methylphenidate and stuttering.

Trenque T, Claustre G, Herlem E, Djerada Z, Trenque A, Morel A, Azzouz B.

Br J Clin Pharmacol. 2019 Aug 16. doi: 10.1111/bcp.14097. [Epub ahead of print]

PMID:
31418914
2.

A probabilistic model of startle response reveals opposite effects of acute versus chronic Methylphenidate treatment.

Zubedat S, Havkin E, Maoz I, Aga-Mizrachi S, Avital A.

J Neurosci Methods. 2019 Aug 12. pii: S0165-0270(19)30246-8. doi: 10.1016/j.jneumeth.2019.108389. [Epub ahead of print]

PMID:
31415846
3.

Acute blood pressure change with methylphenidate is associated with improvement in attention performance in children with ADHD.

Traicu A, Grizenko N, Fortier MÈ, Fageera W, Sengupta SM, Joober R.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Aug 12:109732. doi: 10.1016/j.pnpbp.2019.109732. [Epub ahead of print]

PMID:
31415825
4.

Role of homeostatic feedback mechanisms in modulating methylphenidate actions on phasic dopamine signaling in the striatum of awake behaving rats.

Fuller JA, Burrell MH, Yee AG, Liyanagama K, Lipski J, Wickens JR, Hyland BI.

Prog Neurobiol. 2019 Aug 11:101681. doi: 10.1016/j.pneurobio.2019.101681. [Epub ahead of print]

PMID:
31412279
5.

Randomized Trial of First-Line Behavioral Intervention to Reduce Need for Medication in Children with ADHD.

Coles EK, Pelham Iii WE, Fabiano GA, Gnagy EM, Burrows-MacLean L, Wymbs BT, Chacko A, Walker KS, Wymbs F, Robb Mazzant J, Garefino A, Hoffman MT, Massetti GM, Page TF, Waschbusch DA, Waxmonsky JG, Pelham WE Jr.

J Clin Child Adolesc Psychol. 2019 Aug 14:1-15. doi: 10.1080/15374416.2019.1630835. [Epub ahead of print]

PMID:
31411903
6.

Patch Problems? Characteristics of Transdermal Drug Delivery System Exposures Reported to the National Poison Data System.

Thornton SL, Darracq MA.

J Med Toxicol. 2019 Aug 13. doi: 10.1007/s13181-019-00723-0. [Epub ahead of print]

PMID:
31410729
7.

White Matter by Diffusion MRI Following Methylphenidate Treatment: A Randomized Control Trial in Males with Attention-Deficit/Hyperactivity Disorder.

Bouziane C, Filatova OG, Schrantee A, Caan MWA, Vos FM, Reneman L.

Radiology. 2019 Aug 13:182528. doi: 10.1148/radiol.2019182528. [Epub ahead of print]

PMID:
31407970
8.

[Current approaches to the treatment and correction of Internet addiction].

Egorov AY, Grechanyi SV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(6):152-159. doi: 10.17116/jnevro2019119061152. Russian.

PMID:
31407696
9.

A behavioral economic analysis of the effects of rimcazole on reinforcing effects of cocaine injection and food presentation in rats.

Job MO, Katz JL.

Psychopharmacology (Berl). 2019 Aug 9. doi: 10.1007/s00213-019-05332-x. [Epub ahead of print]

PMID:
31399853
10.

Dose-related concentrations of neuro-/psychoactive drugs expected in blood of children and adolescents.

Fekete S, Hiemke C, Gerlach M.

Ther Drug Monit. 2019 Aug 5. doi: 10.1097/FTD.0000000000000685. [Epub ahead of print]

PMID:
31393331
11.

Jornay PM -- evening-dosed methylphenidate for ADHD.

[No authors listed]

Med Lett Drugs Ther. 2019 Aug 12;61(1578):126-128. No abstract available.

PMID:
31386648
12.

Effect of sweet almond syrup versus methylphenidate in children with ADHD: A randomized triple-blind clinical trial.

Motaharifard MS, Effatpanah M, Karimi M, Akhondzadeh S, Rahimi H, Yasrebi SA, Nejatbakhsh F.

Complement Ther Clin Pract. 2019 Aug;36:170-175. doi: 10.1016/j.ctcp.2019.07.008. Epub 2019 Jul 19.

PMID:
31383435
13.

Personalized at-home neurofeedback compared with long-acting methylphenidate in an european non-inferiority randomized trial in children with ADHD.

Bioulac S, Purper-Ouakil D, Ros T, Blasco-Fontecilla H, Prats M, Mayaud L, Brandeis D.

BMC Psychiatry. 2019 Aug 1;19(1):237. doi: 10.1186/s12888-019-2218-0.

14.

Synthetic Cathinone Analogues Structurally Related to the Central Stimulant Methylphenidate as Dopamine Reuptake Inhibitors.

Yadav-Samudrala BJ, Eltit JM, Glennon RA.

ACS Chem Neurosci. 2019 Aug 15. doi: 10.1021/acschemneuro.9b00284. [Epub ahead of print]

PMID:
31369229
15.

The Effect of Vitamin D Supplementation on Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Gan J, Galer P, Ma D, Chen C, Xiong T.

J Child Adolesc Psychopharmacol. 2019 Aug 1. doi: 10.1089/cap.2019.0059. [Epub ahead of print]

PMID:
31368773
16.

Priapism With Methylphenidate Use in a Preschool-Aged Boy Resolved With Switching to Atomoxetine.

Ekinci O, Üstündağ B, Tunali BD, Abdulrazzaq Al-Bayati MB, Demir H, Adak İ.

Clin Neuropharmacol. 2019 Jul 29. doi: 10.1097/WNF.0000000000000357. [Epub ahead of print]

PMID:
31361667
17.

Population-Based Epidemiology of Pediatric Patients with Treated Tic Disorders from Real-World Evidence in Korea.

Choi S, Lee H, Song DH, Cheon KA.

J Child Adolesc Psychopharmacol. 2019 Jul 30. doi: 10.1089/cap.2019.0050. [Epub ahead of print]

PMID:
31361509
18.

Methylphenidate and atomoxetine normalise fronto-parietal underactivation during sustained attention in ADHD adolescents.

Kowalczyk OS, Cubillo AI, Smith A, Barrett N, Giampietro V, Brammer M, Simmons A, Rubia K.

Eur Neuropsychopharmacol. 2019 Jul 26. pii: S0924-977X(19)30436-5. doi: 10.1016/j.euroneuro.2019.07.139. [Epub ahead of print]

PMID:
31358436
19.

Use of UPLC-HRMS/MS for In Vitro and In Vivo Metabolite Identification of Three Methylphenidate-derived New Psychoactive Substances.

Manier SK, Niedermeier S, Schäper J, Meyer MR.

J Anal Toxicol. 2019 Jul 26. pii: bkz052. doi: 10.1093/jat/bkz052. [Epub ahead of print]

PMID:
31355413
20.

Investigation of the Effects of Methylphenidate, an Amphetamine Derivative, on Intervertebral Disc Tissue Cell Cultures and Matrix Structures.

Kaya YE, Karaarslan N, Yasar Sirin D, Ozbek H, Kaplan N, Yilmaz I.

Turk Neurosurg. 2019 May 30. doi: 10.5137/1019-5149.JTN.26339-19.2. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center